XASXECS
Market cap12mUSD
Jan 07, Last price
0.02AUD
1D
0.00%
1Q
-23.81%
Name
ECS Botanics Holdings Ltd
Chart & Performance
Profile
ECS Botanics Holdings Ltd engages in the cultivation, manufacture, and sale of medicinal cannabis products. It also retails hemp wellness and food products; and engages in the agriculture business. The company is based in Launceston, Australia.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | 2016‑06 | 2015‑06 | |
Income | ||||||||||
Revenues | 20,030 30.16% | 15,389 190.43% | 5,299 325.04% | |||||||
Cost of revenue | 14,461 | 17,674 | 6,916 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 5,569 | (2,285) | (1,617) | |||||||
NOPBT Margin | 27.80% | |||||||||
Operating Taxes | (70) | 263 | 8 | |||||||
Tax Rate | ||||||||||
NOPAT | 5,639 | (2,548) | (1,626) | |||||||
Net income | 1,916 738.76% | 228 -120.47% | (1,115) -74.27% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | 3,800 | 6,196 | ||||||||
BB yield | -18.35% | -35.41% | ||||||||
Debt | ||||||||||
Debt current | 239 | (709) | 19 | |||||||
Long-term debt | 1,809 | 522 | 19 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | (1,110) | (3,607) | (1,861) | |||||||
Cash flow | ||||||||||
Cash from operating activities | (1,486) | 403 | (4,713) | |||||||
CAPEX | (2,392) | (3,299) | (2,920) | |||||||
Cash from investing activities | (2,392) | (37) | (3,856) | |||||||
Cash from financing activities | 4,494 | 311 | 6,190 | |||||||
FCF | (63) | (1,657) | (10,297) | |||||||
Balance | ||||||||||
Cash | 3,158 | 2,542 | 1,866 | |||||||
Long term investments | 878 | 33 | ||||||||
Excess cash | 2,156 | 2,651 | 1,635 | |||||||
Stockholders' equity | 28,213 | 22,202 | 22,170 | |||||||
Invested Capital | 27,080 | 19,882 | 20,554 | |||||||
ROIC | 24.02% | |||||||||
ROCE | 19.05% | |||||||||
EV | ||||||||||
Common stock shares outstanding | 1,218,331 | 1,106,731 | 1,029,128 | |||||||
Price | 0.02 -32.00% | 0.03 47.06% | 0.02 -52.78% | |||||||
Market cap | 20,712 -25.14% | 27,668 58.15% | 17,495 -28.15% | |||||||
EV | 19,602 | 24,061 | 15,634 | |||||||
EBITDA | 6,897 | (1,242) | (955) | |||||||
EV/EBITDA | 2.84 | |||||||||
Interest | 62 | 41 | 4 | |||||||
Interest/NOPBT | 1.11% |